First Time Loading...

GE Healthcare Technologies Inc
NASDAQ:GEHC

Watchlist Manager
GE Healthcare Technologies Inc Logo
GE Healthcare Technologies Inc
NASDAQ:GEHC
Watchlist
Price: 83.4 USD 0.81% Market Closed
Updated: May 11, 2024
Section:
 

Wall Street
Price Targets

GEHC Price Targets Summary
GE Healthcare Technologies Inc

Wall Street analysts forecast GEHC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for GEHC is 95.58 USD with a low forecast of 86.86 USD and a high forecast of 110.25 USD.

GEHC Lowest Forecast
Wall Street Target
86.86 USD
4% Upside
GEHC Average Forecast
Wall Street Target
95.58 USD
15% Upside
GEHC Highest Forecast
Wall Street Target
110.25 USD
32% Upside
Lowest
Price Target
86.86 USD
4% Upside
Average
Price Target
95.58 USD
15% Upside
Highest
Price Target
110.25 USD
32% Upside

GEHC Last Price Targets
GE Healthcare Technologies Inc

The latest public price target was made on May 1, 2024 by Anthony Petrone from Mizuho Securities , who expects GEHC stock to rise by 26% over the next 12 months. You can read more about this price target by viewing the article on StreetInsider.

Analyst Price Target Date Article
Anthony Petrone
Mizuho Securities
105 USD
Upside 26%
1 week ago
May 1, 2024
GE HealthCare (GEHC) PT Lowered to $105 at Mizuho
StreetInsider
Vijay Kumar
Evercore ISI
96 USD
Upside 15%
1 week ago
Apr 30, 2024
GE HealthCare (GEHC) PT Lowered to $96 at Evercore ISI
StreetInsider
Anthony Petrone
Mizuho Securities
110 USD
Upside 32%
1 month ago
Apr 11, 2024
GE HealthCare (GEHC) PT Raised to $110 at Mizuho, Keeps name Top Large-cap Pick, 'see the set-up as net bullish'
StreetInsider
David Toung
Argus Research
110 USD
Upside 32%
1 month ago
Apr 1, 2024
GE HealthCare (GEHC) PT Raised to $110 at Argus
StreetInsider
Patrick Wood
Morgan Stanley
76 USD
Downside 9%
10 months ago
Jun 27, 2023
GE HealthCare's Solid Demand And Sensible Margin Targets: Morgan Stanley Sees Potential Upside Despite Street's High Expectations
Benzinga
Suraj Kalia
Oppenheimer
97 USD
Upside 16%
11 months ago
May 16, 2023
GE HealthCare Technologies Is Innovating An $84B Market And This Analyst Is Bullish
Benzinga
Show More Price Targets
Show Less Price Targets
Anthony Petrone
Mizuho Securities
Price Target 105 USD
Upside/Downside 26%
View Source
Vijay Kumar
Evercore ISI
Price Target 96 USD
Upside/Downside 15%
View Source
Anthony Petrone
Mizuho Securities
Price Target 110 USD
Upside/Downside 32%
View Source
David Toung
Argus Research
Price Target 110 USD
Upside/Downside 32%
View Source
Patrick Wood
Morgan Stanley
Price Target 76 USD
Upside/Downside 9%
View Source
Suraj Kalia
Oppenheimer
Price Target 97 USD
Upside/Downside 16%
View Source
Show More Price Targets
Show Less Price Targets
GE Healthcare Technologies Inc Competitors:
Price Targets
MASI
Masimo Corp
26% Upside
SHL
Siemens Healthineers AG
15% Upside
ABT
Abbott Laboratories
23% Upside
A
688617
APT Medical Inc
9% Downside
MASI
Masimo Corp
26% Upside
SHL
Siemens Healthineers AG
15% Upside
ABT
Abbott Laboratories
23% Upside
A
688617
APT Medical Inc
9% Downside
OPS
Opsens Inc
16% Upside
4106
Wellell Inc
46% Upside
I
041830
InBody Co Ltd
36% Upside
I
099190
I Sens Inc
59% Upside

Revenue
Forecast

Revenue Estimate
GE Healthcare Technologies Inc

For the last 3 years the compound annual growth rate for GE Healthcare Technologies Inc's revenue is 4%. The projected CAGR for the next 3 years is 5%.

4%
Past Growth
5%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
GE Healthcare Technologies Inc

For the last 3 years the compound annual growth rate for GE Healthcare Technologies Inc's operating income is -4%. The projected CAGR for the next 3 years is 17%.

-4%
Past Growth
17%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
GE Healthcare Technologies Inc

For the last 3 years the compound annual growth rate for GE Healthcare Technologies Inc's net income is -54%. The projected CAGR for the next 3 years is 22%.

-54%
Past Growth
22%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average
What are analyst estimates?

See Also

Summary
GEHC intrinsic value, competitors valuation, and company profile.
DCF Valuation
GEHC stock valuation using Discount Cash Flow valuation method.
Relative Valuation
GEHC stock valuation using valuation multiples.
Wall Street Estimates
GEHC price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
GEHC stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GEHC's stock price target?
Price Target
95.58 USD

According to Wall Street analysts, the average 1-year price target for GEHC is 95.58 USD with a low forecast of 86.86 USD and a high forecast of 110.25 USD.

What is GE Healthcare Technologies Inc's Revenue forecast?
Projected CAGR
5%

For the last 3 years the compound annual growth rate for GE Healthcare Technologies Inc's revenue is 4%. The projected CAGR for the next 3 years is 5%.

What is GE Healthcare Technologies Inc's Operating Income forecast?
Projected CAGR
17%

For the last 3 years the compound annual growth rate for GE Healthcare Technologies Inc's operating income is -4%. The projected CAGR for the next 3 years is 17%.

What is GE Healthcare Technologies Inc's Net Income forecast?
Projected CAGR
22%

For the last 3 years the compound annual growth rate for GE Healthcare Technologies Inc's net income is -54%. The projected CAGR for the next 3 years is 22%.

ALPHA SPREAD
Join more than 136,200+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.